Works matching IS 18607179 AND DT 2025 AND VI 20 AND IP 12


Results: 11
    1
    2
    3
    4
    5
    6

    Discovery of ACT‐1002‐4271 as a Dual Prostaglandin E2 Receptor 2/Prostaglandin E2 Receptor 4 Antagonist with In Vivo Anti‐Tumor Efficacy.

    Published in:
    ChemMedChem, 2025, v. 20, n. 12, p. 1, doi. 10.1002/cmdc.202500120
    By:
    • Lyothier, Isabelle;
    • Diethelm, Stefan;
    • Pothier, Julien;
    • Sifferlen, Thierry;
    • Pozzi, Davide;
    • Richard‐Bildstein, Sylvia;
    • Siendt, Hervé;
    • Fretz, Heinz;
    • Boss, Christoph;
    • Wyder, Lorenza;
    • Jeay, Sébastien;
    • de Kanter, Ruben;
    • Gnerre, Carmela;
    • Lehembre, François;
    • Meyer, Dominique S.;
    • Corminboeuf, Olivier
    Publication type:
    Article
    7

    Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists.

    Published in:
    ChemMedChem, 2025, v. 20, n. 12, p. 1, doi. 10.1002/cmdc.202500119
    By:
    • Lyothier, Isabelle;
    • Diethelm, Stefan;
    • Pothier, Julien;
    • Sifferlen, Thierry;
    • Pozzi, Davide;
    • Richard‐Bildstein, Sylvia;
    • Siendt, Hervé;
    • Fretz, Heinz;
    • Boss, Christoph;
    • Wyder, Lorenza;
    • Jeay, Sébastien;
    • de Kanter, Ruben;
    • Gnerre, Carmela;
    • Lehembre, François;
    • Meyer, Dominique S.;
    • Corminboeuf, Olivier
    Publication type:
    Article
    8
    9
    10
    11